Previous Article | Next Article ![]()
Journal of Virology, January 2008, p. 49-59, Vol. 82, No. 1
0022-538X/08/$08.00+0 doi:10.1128/JVI.01497-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Virus Tumor Biology Section, Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, 41 Medlars Dr., Building 41, Room B201, Bethesda, Maryland 20892
Received 9 July 2007/ Accepted 5 October 2007
Human T-lymphotropic virus type 1 (HTLV-1) is the etiologic agent for adult T-cell leukemia. The HTLV-1-encoded protein Tax transactivates the viral long terminal repeat and plays a critical role in virus replication and transformation. Previous work from our laboratory demonstrated that coactivator-associated arginine methytransferase 1, a protein arginine methytransferase, was important for Tax-mediated transactivation. To further investigate the role of methyltransferases in viral transcription, we utilized adenosine-2,3-dialdehyde (AdOx), an adenosine analog and S-adenosylmethionine-dependent methyltransferase inhibitor. The addition of AdOx decreased Tax transactivation in C81, Hut102, and MT-2 cells. Unexpectedly, we found that AdOx potently inhibited the growth of HTLV-1-transformed cells. Further investigation revealed that AdOx inhibited the Tax-activated NF-
B pathway, resulting in reactivation of p53 and induction of p53 target genes. Analysis of the NF-
B pathway demonstrated that AdOx treatment resulted in degradation of the I
B kinase complex and inhibition of NF-
B through stabilization of the NF-
B inhibitor I
B
. Our data further demonstrated that AdOx induced G2/M cell cycle arrest and cell death in HTLV-1-transformed but not control lymphocytes. These studies demonstrate that protein methylation plays an important role in NF-
B activation and survival of HTLV-1-transformed cells.
Published ahead of print on 17 October 2007.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»